PharmaCyte Biotech Inc (PMCB)

[1234jklm]

FDA saw pharmacytes submission and recommended a pivotal trial

Leading gold star oncologists flew to the cancer conference to support the company

The previous clinical trials showed a great and life enhancing benefit for an unmet need.

Td2 is one of the finest oncology institutions in the world and they'll be involved in the trial.

The care, patience and diligence of the company's preparation for ind is impressive and the company has chosen to take its time and get things right. It' has to be perfect.

It takes patience but this is a company with an amazing product and once applied to Mellingen cells for diabetes it will be the solution to the fastest growing illness on the planet.

I and most of the shareholders are long on this stock. Small daily variations of pps on small volume are just noise.

With these sort of results and support thry know how important it is to get the ind submission right.

We are just months away from the ind submission.